TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe March 22, 2013
TCL Archive Francis Collins Nominated For NIH Director Two Days After Final Stem Cell Guidelines Released. July 10, 2009
